Moreover, for GC patients treated with NACT, a higher proportion of ASPH positivity was observed in tumors with poor differentiation than in tumors with moderate or good differentiation (Figure 1C; 62.5% 20/32 vs. 32.4% 11/32, p = 0.014). Here, ASPH is linked to gastric cancer.